Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Consensi (amlodipine/celecoxib)
i
Other names:
KIT 302
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Burke Therap, Coeptis, Purple Biotech
Drug class:
COX2 inhibitor, Ca2+ channel antagonist
Related drugs:
‹
celecoxib (3)
parecoxib (1)
DRGT-46 (1)
CA102N (0)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
amlodipine/atorvastatin (1)
tetrandrine (0)
papaverine (0)
celecoxib (3)
parecoxib (1)
DRGT-46 (1)
CA102N (0)
apricoxib (0)
ECP-1014 (0)
celecoxib oral (0)
ETS2101 (0)
VT-11CR (0)
amlodipine/atorvastatin (1)
tetrandrine (0)
papaverine (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Colon Cancer
No biomarker
Colon Cancer
amlodipine/celecoxib
Resistant: B - Late Trials
amlodipine / celecoxib
Resistant
:
B
amlodipine/celecoxib
Resistant: B - Late Trials
amlodipine / celecoxib
Resistant
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login